Loading...

Haw Par Corporation Limited

HAWPFPNK
Healthcare
Drug Manufacturers - General
$9.40
$0.00(0.00%)

Haw Par Corporation Limited (HAWPF) Stock Overview

Explore Haw Par Corporation Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 73.4/100

Key Financials

Market Cap2.1B
P/E Ratio11.46
EPS (TTM)$0.80
ROE0.06%
Fundamental Analysis

AI Price Forecasts

1 Week$9.40
1 Month$9.19
3 Months$9.60
1 Year Target$8.47

HAWPF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Haw Par Corporation Limited (HAWPF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.08, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $8.47.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 11.46 and a market capitalization of 2.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;